[Early results of the treatment of chronic progressive forms of multiple sclerosis with cyclophosphamide and ACTH]

Neurol Neurochir Pol. 1988 Sep-Oct;22(5):399-403.
[Article in Polish]

Abstract

A group of 16 patients with chronic-progressing type of multiple sclerosis treated by intense immunosuppression (cyclophosphamide and ACTH) were followed-up for one year after completion of therapy. The results were compared with the observation of a control group of 16 patients with a similar type of multiple sclerosis. The choice of the type of therapy was done at random, and the results were assessed by a doctor who ignored the type of therapy used. In only a part of the observed cases stabilization of the disease process was observed, in a greater number in the cases treated with cyclophosphamide and ACTH than in the those treated with ACTH alone. However, the duration of follow-up is regarded as too short for reaching final conclusions regarding the effect of therapy on the course of this type of multiple sclerosis.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Adrenocorticotropic Hormone / administration & dosage*
  • Adult
  • Chronic Disease
  • Clinical Trials as Topic
  • Cyclophosphamide / administration & dosage*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Injections, Intramuscular
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Remission Induction
  • Time Factors

Substances

  • Cyclophosphamide
  • Adrenocorticotropic Hormone